---
document_datetime: 2025-12-02 06:46:25
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/kepivance.html
document_name: kepivance.html
version: success
processing_time: 0.1055769
conversion_datetime: 2025-12-27 21:23:15.351817
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Kepivance

[RSS](/en/individual-human-medicine.xml/66391)

##### Withdrawn

This medicine's authorisation has been withdrawn

palifermin Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 1 April 2016, the European Commission withdrew the marketing authorisation for Kepivance (palifermin) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Swedish Orphan Biovitrum AB (publ), which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Kepivance was granted marketing authorisation in the EU on 25 October 2005 to decrease the incidence, duration and severity of oral mucositis in adult patients with haematological malignancies receiving myeloablative radiochemotherapy associated with a high incidence of severe mucositis and requiring autologous haematopoietic stem cell support. The marketing authorisation holder has committed to ensure that patients who need treatment with Kepivance continue to receive it until complete exhaustion of stock.

The European Public Assessment Report (EPAR) for Kepivance is updated accordingly to indicate that the marketing authorisation is no longer valid.

Kepivance : EPAR - Summary for the public

English (EN) (551.58 KB - PDF)

**First published:** 10/08/2009

**Last updated:** 08/04/2016

[View](/en/documents/overview/kepivance-epar-summary-public_en.pdf)

[Other languages (24)](#file-language-dropdown-417)

български (BG) (1.29 MB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/bg/documents/overview/kepivance-epar-summary-public_bg.pdf)

español (ES) (697 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/es/documents/overview/kepivance-epar-summary-public_es.pdf)

čeština (CS) (1.07 MB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/cs/documents/overview/kepivance-epar-summary-public_cs.pdf)

dansk (DA) (723.35 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/da/documents/overview/kepivance-epar-summary-public_da.pdf)

Deutsch (DE) (761.45 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/de/documents/overview/kepivance-epar-summary-public_de.pdf)

eesti keel (ET) (712.02 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/et/documents/overview/kepivance-epar-summary-public_et.pdf)

ελληνικά (EL) (1.29 MB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/el/documents/overview/kepivance-epar-summary-public_el.pdf)

français (FR) (734.27 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/fr/documents/overview/kepivance-epar-summary-public_fr.pdf)

hrvatski (HR) (790.19 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/hr/documents/overview/kepivance-epar-summary-public_hr.pdf)

íslenska (IS) (725.16 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/is/documents/overview/kepivance-epar-summary-public_is.pdf)

italiano (IT) (730.29 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/it/documents/overview/kepivance-epar-summary-public_it.pdf)

latviešu valoda (LV) (1.08 MB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/lv/documents/overview/kepivance-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (817.91 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/lt/documents/overview/kepivance-epar-summary-public_lt.pdf)

magyar (HU) (1.08 MB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/hu/documents/overview/kepivance-epar-summary-public_hu.pdf)

Malti (MT) (1.1 MB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/mt/documents/overview/kepivance-epar-summary-public_mt.pdf)

Nederlands (NL) (727.76 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/nl/documents/overview/kepivance-epar-summary-public_nl.pdf)

norsk (NO) (687.78 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/no/documents/overview/kepivance-epar-summary-public_no.pdf)

polski (PL) (1.11 MB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/pl/documents/overview/kepivance-epar-summary-public_pl.pdf)

português (PT) (695.67 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/pt/documents/overview/kepivance-epar-summary-public_pt.pdf)

română (RO) (841.19 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/ro/documents/overview/kepivance-epar-summary-public_ro.pdf)

slovenčina (SK) (1.07 MB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/sk/documents/overview/kepivance-epar-summary-public_sk.pdf)

slovenščina (SL) (1.06 MB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/sl/documents/overview/kepivance-epar-summary-public_sl.pdf)

Suomi (FI) (701.32 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/fi/documents/overview/kepivance-epar-summary-public_fi.pdf)

svenska (SV) (705.6 KB - PDF)

**First published:**

10/08/2009

**Last updated:**

08/04/2016

[View](/sv/documents/overview/kepivance-epar-summary-public_sv.pdf)

## Product information

Kepivance : EPAR - Product Information

English (EN) (696.57 KB - PDF)

**First published:** 08/09/2009

**Last updated:** 08/04/2016

[View](/en/documents/product-information/kepivance-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-691)

български (BG) (1.29 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/bg/documents/product-information/kepivance-epar-product-information_bg.pdf)

español (ES) (697 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/es/documents/product-information/kepivance-epar-product-information_es.pdf)

čeština (CS) (1.07 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/cs/documents/product-information/kepivance-epar-product-information_cs.pdf)

dansk (DA) (723.35 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/da/documents/product-information/kepivance-epar-product-information_da.pdf)

Deutsch (DE) (761.45 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/de/documents/product-information/kepivance-epar-product-information_de.pdf)

eesti keel (ET) (712.02 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/et/documents/product-information/kepivance-epar-product-information_et.pdf)

ελληνικά (EL) (1.29 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/el/documents/product-information/kepivance-epar-product-information_el.pdf)

français (FR) (734.27 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/fr/documents/product-information/kepivance-epar-product-information_fr.pdf)

hrvatski (HR) (790.19 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/hr/documents/product-information/kepivance-epar-product-information_hr.pdf)

íslenska (IS) (725.16 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/is/documents/product-information/kepivance-epar-product-information_is.pdf)

italiano (IT) (730.29 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/it/documents/product-information/kepivance-epar-product-information_it.pdf)

latviešu valoda (LV) (1.08 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/lv/documents/product-information/kepivance-epar-product-information_lv.pdf)

lietuvių kalba (LT) (817.91 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/lt/documents/product-information/kepivance-epar-product-information_lt.pdf)

magyar (HU) (1.08 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/hu/documents/product-information/kepivance-epar-product-information_hu.pdf)

Malti (MT) (1.1 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/mt/documents/product-information/kepivance-epar-product-information_mt.pdf)

Nederlands (NL) (727.76 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/nl/documents/product-information/kepivance-epar-product-information_nl.pdf)

norsk (NO) (687.78 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/no/documents/product-information/kepivance-epar-product-information_no.pdf)

polski (PL) (1.11 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/pl/documents/product-information/kepivance-epar-product-information_pl.pdf)

português (PT) (695.67 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/pt/documents/product-information/kepivance-epar-product-information_pt.pdf)

română (RO) (841.19 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/ro/documents/product-information/kepivance-epar-product-information_ro.pdf)

slovenčina (SK) (1.07 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/sk/documents/product-information/kepivance-epar-product-information_sk.pdf)

slovenščina (SL) (1.06 MB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/sl/documents/product-information/kepivance-epar-product-information_sl.pdf)

Suomi (FI) (701.32 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/fi/documents/product-information/kepivance-epar-product-information_fi.pdf)

svenska (SV) (705.6 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

08/04/2016

[View](/sv/documents/product-information/kepivance-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0045 01/04/2016

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Kepivance : EPAR - All Authorised presentations

English (EN) (461.15 KB - PDF)

**First published:** 08/08/2006

**Last updated:** 08/04/2016

[View](/en/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-42)

български (BG) (545.61 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/bg/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_bg.pdf)

español (ES) (461.28 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/es/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_es.pdf)

čeština (CS) (476.37 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/cs/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (461.06 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/da/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (461.9 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/de/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (461.3 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/et/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (496.12 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/el/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_el.pdf)

français (FR) (461.21 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/fr/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (461.19 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/it/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (477.53 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/lv/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (464.69 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/lt/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (474.42 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/hu/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (529.83 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/mt/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (461.25 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/nl/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_nl.pdf)

polski (PL) (476.72 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/pl/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_pl.pdf)

português (PT) (461.3 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/pt/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_pt.pdf)

română (RO) (518.88 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/ro/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (476.53 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/sk/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (474.28 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/sl/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (461.35 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/fi/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (461.5 KB - PDF)

**First published:**

08/08/2006

**Last updated:**

08/04/2016

[View](/sv/documents/all-authorised-presentations/kepivance-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Kepivance Active substance palifermin International non-proprietary name (INN) or common name palifermin Therapeutic area (MeSH) Mucositis Anatomical therapeutic chemical (ATC) code V03AF08

### Pharmacotherapeutic group

All other therapeutic products

### Therapeutic indication

Kepivance is indicated to decrease the incidence, duration and severity of oral mucositis in adult patients with haematological malignancies receiving myeloablative radiochemotherapy associated with a high incidence of severe mucositis and requiring autologous-haematopoietic-stem-cell support.

## Authorisation details

EMA product number EMEA/H/C/000609 Marketing authorisation holder

Swedish Orphan Biovitrum AB (publ)

SE-112 76 Stockholm

Marketing authorisation issued 25/10/2005 Withdrawal of marketing authorisation 01/04/2016 Revision 19

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Kepivance : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (672.64 KB - PDF)

**First published:** 08/09/2009

**Last updated:** 08/04/2016

[View](/en/documents/procedural-steps-after/kepivance-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

CHMP post authorisation positive summary of opinion for Kepivance

Adopted

English (EN) (501.89 KB - PDF)

**First published:** 19/03/2010

**Last updated:** 08/04/2016

[View](/en/documents/smop/chmp-post-authorisation-positive-summary-opinion-kepivance_en.pdf)

## Initial marketing authorisation documents

Kepivance : EPAR - Procedural steps taken before authorisation

English (EN) (476.94 KB - PDF)

**First published:** 08/08/2006

**Last updated:** 08/04/2016

[View](/en/documents/procedural-steps/kepivance-epar-procedural-steps-taken-authorisation_en.pdf)

Kepivance : EPAR - Scientific Discussion

English (EN) (1.52 MB - PDF)

**First published:** 08/08/2006

**Last updated:** 08/04/2016

[View](/en/documents/scientific-discussion/kepivance-epar-scientific-discussion_en.pdf)

**This page was last updated on** 08/04/2016

## Share this page

[Back to top](#main-content)